Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Grade Level 07 Salary Range $17.50-27.31/hour Type of Position Staff Position Time Status Full-Time Required Education HS Click here for more information about equivalencies: https://hr.uky.edu/employment
-
stereotactic surgeries for precise delivery of viral vectors into the brain. Build microwire electrodes. Analyze data using standard and machine learning algorithms. Participate in laboratory meetings and read
-
. Tecnología e Innovación Sanitaria •Research group of the project. Terapias Avanzadas (CIEMAT) •Principal investigator. Juan A. Bueren •Title of the project. CONV/CIEMAT01 Where to apply Website https
-
of the primary tumor and to limit the side effects of anticancer treatments, our project aims to evaluate a multimodal nanoplatform based on the functionalization of gold nanoparticles with: A peptide vector, NDP
-
, KY Grade Level 09 Salary Range $21.00-34.29/hour Type of Position Staff Position Time Status Full-Time Required Education HS Click here for more information about equivalencies: https://hr.uky.edu
-
of vector/delivery systems (e.g., AAV, lentivirus, LNP), treatment of monogenetic diseases (e.g., CRISPR, RNA therapies, etc.), development/automation of bioprocesses for gene and cell therapies, experience
-
-cell suspensions and multi-parameter flow cytometry • Molecular cloning with focus on CRISPR-based approaches • Experience with viral vector systems (e.g., AAV production and purification) • Single-cell
-
Range $19.50-27.31/hour Type of Position Staff Position Time Status Full-Time Required Education HS Click here for more information about equivalencies: https://hr.uky.edu/employment/working-uk
-
gene therapy vectors. We are currently seeking to hire a motivated candidate for a Research Technician III position to assist with in-vivo experimentation and animal husbandry techniques in the lab. A
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 19 hours ago
international leader in the development of Adeno-associated Virus (AAV) vector technology and AAV gene therapy approaches. The AAV technology that was developed by the Gene Therapy Center has been directly or